Date: 2011-03-01
Type of information: R&D agreement
Compound: cancer targets
Company: Philogen (Italy) Pfizer (USA - NY)
Therapeutic area: Cancer - Oncology
Type agreement: R&D
Action mechanism:
Disease: cancer
Details: Philochem AG, the research unit of Philogen S.p.A., has entered a collaborative agreement with Pfizer Inc. in the field of cancer target discovery. No other details have been disclosed.
Financial terms:
Latest news:
